FR2468371A1 - Compositions pharmaceutiques pour nutrition parenterale - Google Patents

Compositions pharmaceutiques pour nutrition parenterale Download PDF

Info

Publication number
FR2468371A1
FR2468371A1 FR8021235A FR8021235A FR2468371A1 FR 2468371 A1 FR2468371 A1 FR 2468371A1 FR 8021235 A FR8021235 A FR 8021235A FR 8021235 A FR8021235 A FR 8021235A FR 2468371 A1 FR2468371 A1 FR 2468371A1
Authority
FR
France
Prior art keywords
carnitine
glucose
acyl
pharmaceutical compositions
compositions according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8021235A
Other languages
English (en)
French (fr)
Other versions
FR2468371B1 (enExample
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2468371A1 publication Critical patent/FR2468371A1/fr
Application granted granted Critical
Publication of FR2468371B1 publication Critical patent/FR2468371B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8021235A 1979-10-05 1980-10-03 Compositions pharmaceutiques pour nutrition parenterale Granted FR2468371A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT50467/79A IT1120033B (it) 1979-10-05 1979-10-05 Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale

Publications (2)

Publication Number Publication Date
FR2468371A1 true FR2468371A1 (fr) 1981-05-08
FR2468371B1 FR2468371B1 (enExample) 1984-05-04

Family

ID=11273028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8021235A Granted FR2468371A1 (fr) 1979-10-05 1980-10-03 Compositions pharmaceutiques pour nutrition parenterale

Country Status (13)

Country Link
US (1) US4320145A (enExample)
JP (1) JPS5661310A (enExample)
AT (1) AT395111B (enExample)
BE (1) BE885527A (enExample)
CA (1) CA1154678A (enExample)
CH (1) CH641675A5 (enExample)
DE (1) DE3037479A1 (enExample)
FR (1) FR2468371A1 (enExample)
GB (1) GB2059262B (enExample)
IL (1) IL61190A (enExample)
IT (1) IT1120033B (enExample)
LU (1) LU82818A1 (enExample)
NL (1) NL8005450A (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
JP2518636B2 (ja) * 1987-02-13 1996-07-24 雪印乳業株式会社 重症感染症及び広範囲熱症治療経腸栄養剤
FR2635264B1 (fr) * 1988-08-12 1992-02-28 Bellon Labor Sa Roger Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
WO2001026649A1 (en) * 1999-10-11 2001-04-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
GB0306394D0 (en) * 2003-03-20 2003-04-23 Univ Nottingham Carnitine retention
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3707M (fr) * 1963-11-05 1965-11-22 Belge Produits Chimiques Sa Association de la carnitine a des émulsions lipidiques.
GB2021410A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing carnitine
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2457689A1 (fr) * 1979-05-29 1980-12-26 Fresenius Chem Pharm Ind Medicament hypolipemique a base de carnitine
EP0046167A1 (de) * 1980-07-11 1982-02-24 LEOPOLD PHARMA GESELLSCHAFT m.b.H. Nährlösung für die vollständige parenterale Ernährung und für gesteigerte Energieproduktion und Verfahren zu deren Herstellung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639532A (enExample) *
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS5460236A (en) * 1977-10-21 1979-05-15 Mitsubishi Electric Corp Etching method
IT1116037B (it) 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3707M (fr) * 1963-11-05 1965-11-22 Belge Produits Chimiques Sa Association de la carnitine a des émulsions lipidiques.
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
GB2021410A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing carnitine
GB2021414A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing an acyl-carnitine
FR2457689A1 (fr) * 1979-05-29 1980-12-26 Fresenius Chem Pharm Ind Medicament hypolipemique a base de carnitine
EP0046167A1 (de) * 1980-07-11 1982-02-24 LEOPOLD PHARMA GESELLSCHAFT m.b.H. Nährlösung für die vollständige parenterale Ernährung und für gesteigerte Energieproduktion und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
IT7950467A0 (it) 1979-10-05
BE885527A (fr) 1981-02-02
GB2059262A (en) 1981-04-23
ATA495580A (de) 1985-03-15
IT1120033B (it) 1986-03-19
IL61190A0 (en) 1980-11-30
US4320145A (en) 1982-03-16
JPS643847B2 (enExample) 1989-01-23
JPS5661310A (en) 1981-05-26
CH641675A5 (it) 1984-03-15
LU82818A1 (fr) 1981-02-02
DE3037479C2 (enExample) 1988-09-08
AT395111B (de) 1992-09-25
FR2468371B1 (enExample) 1984-05-04
DE3037479A1 (de) 1981-05-21
NL8005450A (nl) 1981-04-07
CA1154678A (en) 1983-10-04
IL61190A (en) 1984-06-29
GB2059262B (en) 1983-11-09

Similar Documents

Publication Publication Date Title
FR2468371A1 (fr) Compositions pharmaceutiques pour nutrition parenterale
Ginguay et al. Indications and contraindications for infusing specific amino acids (leucine, glutamine, arginine, citrulline, and taurine) in critical illness
JP2873497B2 (ja) 脂質代謝調節剤
US5756481A (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction in animals and man
US20120178672A1 (en) Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
CN101820871A (zh) 可提高血液精氨酸水平的含有瓜氨酸和精氨酸的速效口服制剂
IL272309A (en) Amino acid compounds for the treatment of liver disease
CN101605538A (zh) 瓜氨酸用于治疗营养缺乏状况的用途
EP1349578B1 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
Pinto et al. Administration of aspartame potentiates pentylenetetrazole-and fluorothyl-induced seizures in mice
EP0655244B1 (fr) Composition à base d'acides aminés pour le traitement d'infections
Obeso et al. Continuous dopaminergic stimulation in Parkinson's disease
FR2556593A1 (fr) Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
EP0354848B1 (fr) Compositions pharmaceutiques et/ou diététiques contenant de la L-carnitine et de la L-lysine
JPS61502822A (ja) 全非経口栄養及び経腸栄養組成物
EP1495755A1 (fr) Utilisation de la citrulline dans la fabrication d'un médicament pour le traitement de l'insuffisance intestinale
Maksoud et al. Effect of branched‐chain amino acids and insulin on postinjury protein catabolism in growing animals
JP3096052B2 (ja) 脂質代謝調節剤
FR2643266A1 (fr) Solute d'apport d'acides amines pour alimentation parenterale
BE887941A (fr) Produits nutritifs et leur procede d'administration.
JPH02121928A (ja) Ｌ−チロシンのジペプチドを含有する栄養輸液組成物
Keller et al. Protein‐sparing therapy in the postoperative period
Kishi et al. Amino acid levels in plasma and muscle of rats after intravenous administration of different amino acid infusions
EP4479027A1 (en) Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor
Schricker et al. Effects of hypocaloric glucose vs glucosexylitol (1: 1) and carbohydrate metabolism after coronary artery bypass grafting operation